MAPT and Alzheimer disease: Interestingly, in vitro, Hsp90 and Hsp70 also delay tau aggregation, but with CDK2-modified tau, which produces a tau phosphorylation profile similar to that seen in AD and has a decreased affinity for Hsp90, whereas Hsp90 alone accelerated modified tau fibrilization.132